1/29/2013

A dual-hormone closed-loop delivery system fared better than traditional pump treatment in improving glycemic control and curbing hypoglycemia risk in diabetes patients, researchers wrote in the Canadian Medical Association Journal. The system also helped increase how long patients spent at target plasma glucose levels, they added.

Related Summaries